Unknown PHASE1/PHASE2 INTERVENTIONAL 3-arm NCT02816840

PET-CT/MRI in the Radiotherapy for Prostate Cancer

Pilot Study of the Incorporation of PET-CT/MRI in the Radiotherapy for Prostate Cancer

Sponsor: Xuzhou Medical University

Updated 6 times since 2017 Last updated: Jun 28, 2016 Started: Sep 30, 2016 Primary completion: Aug 31, 2019 Completion: Aug 31, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02816840, this PHASE1/PHASE2 trial focuses on Prostate Cancer and remains ongoing. Sponsored by Xuzhou Medical University, it has been updated 6 times since 2016, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1/PHASE2

Status: Unknown Status → Unknown · Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE1_PHASE2
Sep 2019 — Jan 2021 [monthly]

Unknown Status PHASE1_PHASE2

Status: Not Yet Recruiting → Unknown Status
Jun 2018 — Sep 2019 [monthly]

Not Yet Recruiting PHASE1_PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Not Yet Recruiting PHASE1_PHASE2

First recorded

Sep 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Xuzhou Medical University

Data source: Xuzhou Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.